• Gene deletion; HGNC; HGNC:950; BAP1; Zygosity=Heterozygous (PubMed=21642991).
  
• Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=21642991).
  

PubMed=16475242; DOI=10.1002/jgm.877; PMCID=PMC1804293
Prasad S. Adusumilli, Brendon M. Stiles, Mei-Ki Chan, Michael Mullerad, David P. Eisenberg, Leah Ben-Porat, Rumana Huq, Valerie W. Rusch, Yu-Man Fong;
Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses.
J. Gene Med. 8:603-615(2006)

PubMed=21642991; DOI=10.1038/ng.855; PMCID=PMC4643098
Matthew J. Bott, Marie Brevet, Barry Stephen Taylor, Shigeki Shimizu, Tatsuo Ito, Lu Wang, Jenette Creaney, Richard A. Lake, Maureen F. Zakowski, Boris A. Reva, Chris Sander ...Show all 18 authors... , Robert Delsite, Simon N. Powell, Qin Zhou, Rong-Lai Shen, Adam B. Olshen, Valerie W. Rusch, Marc Ladanyi; Show fewer authors
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.
Nat. Genet. 43:668-672(2011)

PubMed=21774103; DOI=10.1097/JTO.0b013e318215a07d
Marie Brevet, Shigeki Shimizu, Matthew J. Bott, Neerav Shukla, Qin Zhou, Adam B. Olshen, Valerie W. Rusch, Marc Ladanyi;
Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy.
J. Thorac. Oncol. 6:864-874(2011)